tiprankstipranks
Trending News
More News >
Glenmark Pharmaceuticals Limited (IN:GLENMARK)
:GLENMARK
India Market
Advertisement

Glenmark Pharmaceuticals Limited (GLENMARK) Revenue

Compare
1 Followers

Glenmark Pharmaceuticals Limited Revenue

Glenmark Pharmaceuticals Limited had a revenue of 32.20B in the quarter ending Mar 31, 2025, with -2.48%. This bring the company's revenue in the last twelve months to 131.67B, Decreased 1.21%. In the fiscal year ending Mar 31, 2025, Glenmark Pharmaceuticals Limited had annual revenue of 131.46B with 11.28% growth.
Revenue (ttm)
131.67B
Revenue Growth
9.39%
P/S Ratio
4.77
Revenue/Employee
₹8,770,322
Employees
14,989
Market Cap
₹627.35B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Mar 31, 2025
131.46B13.33B+11.28%
Mar 31, 2024
118.13B2.30B+1.98%
Mar 31, 2023
115.83B-5.91B-4.85%
Mar 31, 2022
121.74B13.68B+12.66%
Mar 31, 2021
108.06B1.49B+1.40%
Mar 31, 2020
106.57B9.52B+9.81%
Mar 31, 2019
97.05B7.62B+8.51%
Mar 31, 2018
89.44B797.62M+0.90%
Mar 31, 2017
88.64B
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis